Close

Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Sells]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $152.00 (+164.1%) * Over Last 12-Mos
Rating Score: 4.4 / 10   Percentile Rank: 45%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/19/2012 Jefferies
» Updated 5/5/2015
N/A Downgrade Underperform
(Buy)
11.00
(10.00)
14.03
(57.56)
310.26% Details